Patents by Inventor Barbara K Finck

Barbara K Finck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS
    Publication number: 20170096471
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: September 8, 2016
    Publication date: April 6, 2017
    Applicant: Immunex Corporation
    Inventor: Barbara K. Finck
  • SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS
    Publication number: 20140212420
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: March 25, 2014
    Publication date: July 31, 2014
    Applicant: Immunex Corporation
    Inventor: Barbara K. FINCK
  • Soluble tumor necrosis factor receptor treatment of medical disorders
    Patent number: 8722631
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: May 13, 2014
    Assignee: Immunex Corporation
    Inventor: Barbara K. Finck
  • Soluble tumor necrosis factor receptor treatment of medical disorders
    Patent number: 8410060
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: April 2, 2013
    Assignee: Immunex Corporation
    Inventor: Barbara K. Finck
  • SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS
    Publication number: 20120135933
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: February 6, 2012
    Publication date: May 31, 2012
    Applicant: Immunex Corporation
    Inventor: Barbara K. FINCK
  • Soluble tumor necrosis factor receptor treatment of medical disorders
    Patent number: 8119605
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: February 21, 2012
    Assignee: Immunex Corporation
    Inventor: Barbara K. Finck
  • SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS
    Publication number: 20110142832
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: February 4, 2011
    Publication date: June 16, 2011
    Applicant: Immunex Corporation
    Inventor: Barbara K. FINCK
  • Soluble tumor necrosis factor receptor treatment of medical disorders
    Patent number: 7915225
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: March 29, 2011
    Assignee: Immunex Corporation
    Inventor: Barbara K Finck
  • SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS
    Publication number: 20090163424
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: February 27, 2009
    Publication date: June 25, 2009
    Applicant: IMMUNEX CORPORATION
    Inventors: Barbara K. FINCK, Larry O'Neal, John D. Pluenneke, Timothy Connor
  • Soluble tumor necrosis factor receptor treatment of medical disorders
    Publication number: 20040220103
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF&agr; by administering a TNF&agr; antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: May 25, 2004
    Publication date: November 4, 2004
    Applicant: Immunex Corporation
    Inventors: Barbara K. Finck, Larry O'Neal, John D. Pluenneke, Timothy Connor